Researchers at Pennsylvania State University are developing a portable testing device that could detect endometriosis by analyzing menstrual blood. The device targets a protein biomarker called HMGB1, which is present in period blood and associated with the progression of endometriosis. This condition is notoriously difficult to diagnose, often taking years due to invasive procedures and nonspecific symptoms.
How the Test Works
The proposed device works by identifying elevated levels of HMGB1 in menstrual blood samples. HMGB1 is a protein that acts as a damage-associated molecular pattern molecule, triggering inflammation and pain in endometriosis patients. By measuring its concentration, the device could indicate the presence and severity of the disease.
Potential Impact on Diagnosis
Current diagnostic methods for endometriosis include pelvic exams, ultrasound, and laparoscopic surgery, which is invasive and costly. A simple, noninvasive test using period blood could significantly reduce diagnosis time and improve access to care, especially in resource-limited settings. Early detection may allow for timely treatment and better management of symptoms.
Research and Development
The team is working on a handheld prototype that can process menstrual blood samples quickly. Initial studies have shown that HMGB1 levels correlate with endometriosis stage. Further clinical trials are needed to validate the device's accuracy and reliability before it can be made widely available.
This innovation holds promise for millions of women worldwide who suffer from endometriosis, a condition affecting about 10% of women of reproductive age. The portable nature of the device could also enable at-home testing, empowering women to monitor their reproductive health more proactively.
